Kiniksa Pharmaceuticals International, plc Stock Issued During Period, Value, Acquisitions
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Kiniksa Pharmaceuticals International, plc stock issued during period, value, acquisitions for the quarter ending 2019-03-31 was $7.00M.
- Kiniksa Pharmaceuticals International, plc stock issued during period, value, acquisitions for fiscal 2019 was $7.00M.
| Period end | Stock Issued During Period, Value, Acquisitions 3 month | Stock Issued During Period, Value, Acquisitions 12 month |
|---|---|---|
| 2019-12-31 | $7.00M 10-K · filed 2022-02-24 | |
| 2019-03-31 | $7.00M 10-Q · filed 2020-11-05 |